EDGAR Filing Documents for 0001144204-13-032230

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-13-032230

Filing Date

2013-05-30

Accepted

2013-05-30 09:27:40

Documents

Period of Report

2013-05-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v346458_6k.htm	6-K	885332
2	GRAPHIC	tlogo.jpg	GRAPHIC	9060
3	GRAPHIC	tlogo2.jpg	GRAPHIC	4292
	Complete submission text file	0001144204-13-032230.txt		905011

Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140

Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 13880046
SIC: 2834 Pharmaceutical Preparations